Skip to content
Studies have shown that active fund managers routinely underperform the S&P500 index*
Home
Articles
WALL STREET X
Forecasts
Portfolios
Wall Street X
Articles
Forecasts
Portfolios
Search
Results for
{phrase}
(
{results_count}
of
{results_count_total}
)
Displaying
{results_count}
results of
{results_count_total}
Kyntra Bio, Inc. (NASDAQ: KYNB)
KYNB Stock Predictions and Ratings
WSX Rating:
BUY
WSX Forecast (1yr):
8.70%
Analyst Rating:
NOT AVAILABLE
Analyst Forecast (1yr):
NOT AVAILABLE
KYNB Stock Analysis
KYNB
PE Ratio:
0.2
KYNB
PEG Ratio:
Not Available
KYNB
Forward EPS Growth (12 month):
0.00%
KYNB
PS Ratio:
3.7
KYNB
PSG Ratio:
0.1
KYNB
Forward Revenue Growth (12 month):
39.80%
KYNB Articles
No data was found